Panuveitis associated with multiple sclerosis complicated by cerebral venous thrombosis.
OBJECTIVE
To report cerebral venous thrombosis as a complication of intravenous corticosteroid treatment in a patient with multiple sclerosis.


METHODS
A case report. A 44-year-old woman with a previous diagnosis of multiple sclerosis presented with panuveitis and retinal perivasculitis. Intravenous pulse corticosteroid therapy was given for three days.


RESULTS
The panuveitis and retinal periphlebitis began to resolve within one week; however, ten days after the last corticosteroid dose, the patient was hospitalized with the diagnosis of cerebral venous thrombosis.


CONCLUSIONS
Although intravenous corticosteroid treatment for uveitis associated with multiple sclerosis can be very helpful, the patient should be monitored closely for systemic side effects.
Kadayifçilar
Sibel
S
Department of Ophthalmology, Hacettepe University School of Medicine, Ankara, Turkey. sibelk@hacettepe.edu.tr
Gedik
Sansal
S
Eldem
Bora
B
Balaban
Hatice
H
Kansu
Tülay
T
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D002550:Cerebral Veins; D005260:Female; D005451:Fluorescein Angiography; D005654:Fundus Oculi; D006801:Humans; D007275:Injections, Intravenous; D008775:Methylprednisolone / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D009103:Multiple Sclerosis / Q000150:complications*; D015864:Panuveitis / Q000188:drug therapy* / Q000209:etiology*; D010689:Phlebitis / Q000175:diagnosis / Q000209:etiology; D012169:Retinal Vein; D020246:Venous Thrombosis / Q000139:chemically induced*
D000893:Anti-Inflammatory Agents; D008775:Methylprednisolone